Imax Corp’s filing revealed that its Director Demirian Eric A unloaded Company’s shares for reported $0.62 million on Feb 24 ’25. In the deal valued at $26.81 per share,23,000 shares were sold. As a result of this transaction, Demirian Eric A now holds 35,007 shares worth roughly $0.88 million.
Then, Fernandes Natasha sold 2,957 shares, generating $75,448 in total proceeds. Upon selling the shares at $25.52, the Chief Financial Officer & EVP now owns 14,883 shares.
Before that, Weissman Kenneth Ian sold 6,309 shares. Imax Corp shares valued at $160,927 were divested by the Deputy GC, Corp. Sec. & CCO at a price of $25.51 per share. As a result of the transaction, Weissman Kenneth Ian now holds 25,139 shares, worth roughly $0.63 million.
Seaport Research Partners initiated its Imax Corp [IMAX] rating to a Buy in a research note published on July 24, 2024; the price target was $23. A number of analysts have revised their coverage, including Barrington Research’s analysts, who remained covering the stock and in late April has reiterated a ‘”an Outperform”‘ rating for it. B. Riley Securities also remained covering IMAX and reiterated its “Buy” recommendation on December 05, 2022. B. Riley Securities maintained its rating on October 12, 2022. It rated IMAX as “a Buy”.
Price Performance Review of IMAX
On Monday, Imax Corp [NYSE:IMAX] saw its stock fall -2.27% to $25.02. Over the last five days, the stock has lost -4.76%. Imax Corp shares have fallen nearly -2.27% since the year began. Nevertheless, the stocks have risen 42.65% over the past one year. While a 52-week high of $27.77 was reached on 02/21/25, a 52-week low of $14.94 was recorded on 01/16/25. SMA at 50 days reached $24.74, while 200 days put it at $21.38.
Levels Of Support And Resistance For IMAX Stock
The 24-hour chart illustrates a support level at 24.72, which if violated will result in even more drops to 24.41. On the upside, there is a resistance level at 25.57. A further resistance level may holdings at 26.11. The Relative Strength Index (RSI) on the 14-day chart is 45.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.86%. Stochastics %K at 12.68% indicates the stock is a buying.
The most recent change occurred on May 24, 2022 when Rosenblatt began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
